Skip to main content

Table 1 Baseline (week 0) characteristics of study participants

From: The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome

BMI Greater than 30 (Obese) 25 – 29 (Overweight)
Treatment Placebo (n = 30) Formulation/no diet (n = 31) Formulation/Diet (n = 31) Formulation/no diet (n = 31)
Demographic Characteristics (no.)     
Sex     
   Male 14 15 14 15
   Female 16 16 17 16
Age (years)* 39.9 (9.6) 41.0 (9.4) 40.9 (9.8) 39.7 (9.9)
Race or ethnic group     
   West African 30 31 31 31
Family History of Diabetes 2 1 0 2
History of Gestational Diabetes 2 2 3 2
Anthropomorphic Characteristics* 1     
Weight (kg) 95.6 (14.3) 95.8 (8.0) 95.3 (9.1) 76.3 (7.9)
Fat (%) 41.8 (5.2) 46.5 (5.8) 48.1 (3.0) 35.8 (5.2)
Body Mass Index (kg/m2) 38.4 (1.6) 37.7 (1.5) 37.5 (1.0) 27.3 (0.7)
Waist Circumference (cm) 103.4 (8.1) 98.6 (4.6) 97.8 (5.7) 86.9 (3.2)
Serological Characteristics* 2     
Total Cholesterol (mg/dl) 160.8 (18.0) 159.1 (30.7) 171.0 (24.4) 152.6 (26.9)
LDL Cholesterol (mg/dl) 103.5 (14.9) 99.8 (11.7) 116.6 (15.4) 101.6 (17.0)
HDL Cholesterol (mg/dl) 32.7 (7.5) 36.6 (8.0) 38.6 (7.1) 44.4 (9.8)
Triglycerides (mg/dl) 142.5 (31.8) 156.0 (25.3) 144.9 (30.0) 117.4 (25.3)
C-Reactive Protein (mg/dl) 8.0 (1.1) 8.0 (1.0) 8.1 (0.7) 7.8 (0.8)
Fasting Blood Glucose (mg/dl) 101.6 (11.9) 101.2 (15.9) 102.4 (9.8) 93.3 (12.4)
  1. * These data are shown as means with standard deviations in parentheses
  2. 1 Primary outcome measures
  3. 2 Secondary outcome measures